Nav1.7 sodium channel modulators (Xenon Pharmaceuticals)

N/A

Report date: 2024/07/05 09:46:16
NME

Base Information

Drug NameNav1.7 sodium channel modulators (Xenon Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit modulators
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesXenon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A